1Use of sensory substitution devices as a model system for investigating cross-modal neuroplasticity in humansPERSPECTIVES1717-1719
2Studying neurological disorders using induced pluripotent stem cells and optogeneticsPERSPECTIVES1720-1722
4VEGF in the nervous system: an important target for research in neurodevelopmental and regenerative medicinePERSPECTIVES1725-1726
5Intracellular sorting pathways of the amyloid precursor protein provide novel neuroprotective strategiesPERSPECTIVES1727-1728
7Animal model of repetitive mild traumatic brain injury for human traumatic axonal injury and chronic traumatic encephalopathyPERSPECTIVES1731-1732
8Immunization with Cop-1 promotes neuroprotection and neurogenesis after ischemic strokePERSPECTIVES1733-1734
9Who is who after spinal cord injury and repair? Can the brain stem descending motor pathways take control of skilled hand motor function?PERSPECTIVES1735-1736
10Propriospinal interneurons in the spotlight for anatomical and functional recovery after spinal cord injuryPERSPECTIVES1737-1738
12Compliant semiconductor scaffolds: building blocks for advanced neural interfacesPERSPECTIVES1741-1742
13Novel approaches for the development of peripheral nerve regenerative therapiesPERSPECTIVES1743-1745
14pFTAA: a high affinity oligothiophene probe that detects filamentous tau in vivo and in cultured neuronsPERSPECTIVES1746-1747
15A role for mitogen-activated protein kinase phosphatase 1 (MKP1) in neural cell development and survivalPERSPECTIVES1748-1749
16Antiglycative activity of sulforaphane: a new avenue to counteract neurodegeneration?PERSPECTIVES1750-1751
17The neuroprotective and regenerative potential of parkin and GDNF/ Ret signaling in the midbrain dopaminergic systemPERSPECTIVES1752-1753
18Cognitive training in neurodegenerative diseases: a way to boost neuroprotective molecules?PERSPECTIVES1754-1755
